Filter
2214
Filtered Results: 2214
Text search:
Drug
Safety
Monitoring
Programme
Featured
Recommendations
247
New Publications
715
Language
Document type
No document type
1353
Guidelines
321
Studies & Reports
270
Manuals
116
Strategic & Response Plan
98
Training Material
23
Fact sheets
18
Situation Updates
8
Infographics
4
Resource Platforms
2
Online Courses
1
Countries / Regions
India
156
Kenya
77
South Africa
63
Global
62
Nigeria
59
Uganda
54
Nepal
48
Sierra Leone
45
Western and Central Europe
44
Tanzania
43
Ghana
40
Zambia
38
Ethiopia
37
Myanmar / Burma
37
Malawi
35
Bangladesh
31
Liberia
31
Africa
29
Namibia
27
Lesotho
19
Eastern Europe
19
South–East Asia Region
18
Rwanda
16
Zimbabwe
16
Cambodia
15
Asia
14
Latin America and the Carribbean
13
Botswana
13
Ukraine
12
Syria
12
Philippines
12
Congo, Democratic Republic of
10
Indonesia
10
Russia
8
Tajikistan
7
Cameroon
7
South Sudan
7
Eswatini/ Swaziland
7
Albania
6
Senegal
6
West and Central Africa
6
Western Pacific Region
6
Eastern Europe and Central Asia
6
East and Southern Africa
6
Pakistan
6
Thailand
5
Burkina Faso
5
Middle East and North Africa
5
Laos
4
Guinea
4
Mozambique
4
Afghanistan
3
Germany
3
Sudan
3
Georgia
3
Iraq
3
Benin
2
China
2
Kyrgyzstan
2
USA
2
Haiti
2
United Kingdom
2
Brazil
2
Sri Lanka
2
Bhutan
2
Somalia
2
North Macedonia
1
Colombia
1
Timor Leste/ East Timor
1
El Salvador
1
Serbia
1
Turkey
1
Gambia
1
Kazakhstan
1
Canada
1
Singapore
1
Uzbekistan
1
Peru
1
Qatar
1
Bulgaria
1
Lithuania
1
Jordan
1
Ireland
1
Paraguay
1
North America
1
Gabon
1
Turkmenistan
1
Denmark
1
Maldives
1
Mauritius
1
Southern Africa
1
Lebanon
1
Vietnam
1
Moldova
1
Yemen
1
Central African Republic
1
Poland
1
Honduras
1
Angola
1
Libya
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
915
Clinical Guidelines
235
Public Health
142
Women & Child Health
105
Key Resources
73
Pharmacy & Technologies
41
Capacity Building
36
Toolboxes
HIV
254
TB
190
AMR
146
Mental Health
131
COVID-19
76
Pharmacy
75
Caregiver
51
NTDs
51
Rapid Response
48
NCDs
44
Ebola
38
Planetary Health
33
Conflict
28
Global Health Education
28
Disability
24
Refugee
22
Natural Hazards
10
Polio
10
Cholera
9
Health Financing Toolbox
9
Specific Hazards
8
Zika
5
Introduction Pharmacovigilance (PV) systems to monitor drug and vaccine safety are often inadequate in sub-Saharan
Africa. In Malawi, a PV enhancement initiative was introduced to address major barriers to PV.
Objective The objective of this initiative was to improve reporting of adverse events (A...
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International Drug...
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f...
Framework for implementation.
The END TB Strategy.
Reporting system for the general public - This document aims to provide practical guidelines on how to set up national systems for consumers to report adverse reactions to medicines. The purpose is to help countries set up a well-organized and effective consumer reporting system within their pharmac...
Antimicrobial resistance (AMR) is a global human, animal, plant and environment health threat that needs to be addressed by every country. The impacts of AMR are wide-ranging in terms of human health, animal health, food security and safety, environmental effects on ecosystems and biodiversity, and ...
This manual summarizes key issues related to the safety of NTD medicines and their administration, with a focus on essential medicines used in mass drug administration (MDA), also called preventive chemotherapy. It can be used as a standalone reference manual, but is intended to be used in conjuncti...
Specific measures are being taken within the National Tuberculosis Control Programme (NTP) to address the MDR TB problem through appropriate management of patients and strategies to prevent the propagation and dissemination of MDR TB.
The term "Programmatic Management of Drug Resistant TB" (PMD...
The term "Programmatic Management of Drug Resistant TB" (PMD...
Made under Section 5 (c) of the Tanzania Food, Drugs and Cosmetics Act, 2003 | Second Edition
Confronted with the important issue of patient safety, in 2002 the Fifty-fifth World Health Assembly adopted a resolution urging countries to pay the closest possible attention to the problem and to strengthen safety and monitoring systems. In May 2004, the Fifty-seventh World Health Assembly approv...
The safety of medicines in Zambia - why health workers need to take action | Produced by the National Pharmacovigilance Unit (NPVU)
Following the encouraging initial results of the pilot project, the Ministry of Health is committed to increasing access to MDR-TB diagnosis, treatment and care. An expansion plan for the programmatic management of drug-resistant TB has been developed and forms part of the Five Year National Strateg...
Therapeutics Information and Pharmacovigilance Centre | TIPC
UNAIDS/WHO Working group
HIV/AIDS and STI surveillance 2015 / Reference
